Clear Creek Financial Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$656K Sell
1,812
-75
-4% -$25.7K 0.04% 349
2026
Q1
$664K Buy
1,887
+40
+2% +$14.3K 0.05% 329
2025
Q4
$604K Sell
1,847
-591
-24% -$187K 0.05% 328
2025
Q3
$688K Buy
2,438
+390
+19% +$113K 0.06% 302
2025
Q2
$572K Sell
2,048
-110
-5% -$31.2K 0.05% 332
2025
Q1
$672K Buy
2,158
+82
+4% +$24.2K 0.07% 264
2024
Q4
$541K Buy
2,076
+8
+0.4% +$2.37K 0.06% 284
2024
Q3
$666K Sell
2,068
-44
-2% -$14.4K 0.08% 217
2024
Q2
$660K Buy
2,112
+344
+19% +$101K 0.08% 211
2024
Q1
$503K Buy
1,768
+1,000
+130% +$293K 0.06% 245
2023
Q4
$221K Sell
768
-32
-4% -$8.72K 0.04% 301
2023
Q3
$215K Buy
+800
New +$200K 0.04% 282
2022
Q3
Sell
-882
Closed -$215K 285
2022
Q2
$215K Buy
+882
New +$216K 0.05% 266

Other funds holding AMGN

Clear Creek Financial Management's AMGN Position: Q2 2026 in Review

Clear Creek Financial Management reduced its Amgen (AMGN) stake by 4% in Q2 2026, selling an estimated $25.7K and leaving 1,812 shares worth $656K. The position accounts for 0.04% of the portfolio, ranked #349.

Clear Creek Financial Management first reported a position in AMGN in Q2 2022 and has held it in 13 quarters since. The position peaked at $688K in Q3 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Clear Creek Financial Management held 1,812 shares of Amgen worth $656K as of Q2 2026.
  • Clear Creek Financial Management sold 75 Amgen shares in Q2 2026, an estimated $25.7K.
  • Amgen made up 0.04% of Clear Creek Financial Management's portfolio in Q2 2026, its #349 holding.
  • Clear Creek Financial Management first reported a position in Amgen in Q2 2022 and has held it in 13 quarters since.
  • Clear Creek Financial Management's Amgen position peaked at $688K in Q3 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.